Salvianolic acid A & B: potential cytotoxic polyphenols in battle against cancer via targeting multiple signaling pathways.
Salvianolic acids
anticancer activity
natural products
Journal
International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
06
2019
accepted:
11
07
2019
entrez:
9
10
2019
pubmed:
9
10
2019
medline:
28
4
2020
Statut:
epublish
Résumé
Nature has generously offered life-saving therapies to mankind by providing evolutionarily optimized drug-like entities in the form of natural products. These splendid gifts of nature have served as most suitable candidates for anti-cancer drug discovery due to their pleiotropic activity on target molecules. This review aims to provide an update on the natural sources and bioactivities of such gifts from nature, salvianolic acid A & B, which are major bioactive constituents of a traditional Chinses medicinal herb,
Identifiants
pubmed: 31592132
doi: 10.7150/ijbs.37467
pii: ijbsv15p2256
pmc: PMC6775286
doi:
Substances chimiques
Antineoplastic Agents
0
Benzofurans
0
Caffeic Acids
0
Drugs, Chinese Herbal
0
Lactates
0
Polyphenols
0
salvianolic acid A
51622542XO
salvianolic acid B
C1GQ844199
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2256-2264Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Cancer Prev Res (Phila). 2010 Jun;3(6):787-96
pubmed: 20501859
Cell Cycle. 2014;13(24):3808-17
pubmed: 25426675
Protein Cell. 2013 Mar;4(3):176-85
pubmed: 23483479
Mol Med Rep. 2018 Aug;18(2):1323-1334
pubmed: 29845279
Mol Cancer. 2018 Feb 19;17(1):45
pubmed: 29455668
Eur J Gynaecol Oncol. 2016;37(5):653-656
pubmed: 29787004
Expert Opin Ther Targets. 2012 Jan;16(1):103-19
pubmed: 22239440
Curr Top Med Chem. 2014;14(20):2272-85
pubmed: 25434355
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Cancer Immunol Res. 2014 Sep;2(9):823-30
pubmed: 25187272
J Oncol. 2011;2011:534548
pubmed: 21209716
BMC Cancer. 2018 Oct 1;18(1):939
pubmed: 30285678
Biomed Pharmacother. 2018 Nov;107:1230-1236
pubmed: 30257337
Colloids Surf B Biointerfaces. 2016 Nov 1;147:65-72
pubmed: 27490455
Front Pharmacol. 2019 Feb 20;10:97
pubmed: 30842735
J Adv Pharm Technol Res. 2012 Oct;3(4):200-1
pubmed: 23378939
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Mol Med Rep. 2017 Feb;15(2):724-730
pubmed: 28000873
J Asian Nat Prod Res. 2008 May-Jun;10(5-6):391-6
pubmed: 18464075
Cancer Res. 2005 Jan 1;65(1):130-6
pubmed: 15665288
Phytomedicine. 2014 Oct 15;21(12):1725-32
pubmed: 25442283
Oncotarget. 2014 May 15;5(9):2736-49
pubmed: 24811362
BMC Complement Altern Med. 2016 Jul 19;16:230
pubmed: 27430329
Nature. 2000 Oct 12;407(6805):770-6
pubmed: 11048727
BMC Complement Altern Med. 2011 Jul 05;11:54
pubmed: 21726465
Int J Mol Sci. 2015 Dec 09;16(12):29345-56
pubmed: 26690140
Nutrients. 2016 Sep 09;8(9):
pubmed: 27618095
Genes Cancer. 2010 Dec;1(12):1170-7
pubmed: 21779440
Pak J Pharm Sci. 2014 Sep;27(5 Spec no):1477-82
pubmed: 25176241
Int J Mol Sci. 2015 Sep 03;16(9):21138-52
pubmed: 26404259
Carcinogenesis. 2006 Apr;27(4):826-32
pubmed: 16286460
Biotechnol Adv. 2015 Dec;33(8):1582-1614
pubmed: 26281720
Chin Med. 2006 Nov 23;1:3
pubmed: 17302964
Oncotarget. 2017 Sep 28;8(60):101599-101613
pubmed: 29254189
Anal Bioanal Chem. 2009 Feb;393(4):1297-303
pubmed: 19066864
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):270-8
pubmed: 20716914
Cancer Biol Ther. 2015;16(9):1407-14
pubmed: 26176734
Int J Cancer. 2009 May 1;124(9):2200-9
pubmed: 19123475
Planta Med. 2014 Jan;80(1):70-6
pubmed: 24414309
Int J Nanomedicine. 2016 Nov 02;11:5709-5727
pubmed: 27843313
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):155-76
pubmed: 26739136
J Pharmacol Sci. 2017 Sep;135(1):1-7
pubmed: 28939129
Cell Mol Neurobiol. 2013 Oct;33(7):921-8
pubmed: 23842993
Molecules. 2017 Jun 21;22(6):null
pubmed: 28635648
Nat Prod Bioprospect. 2015 Dec;5(6):307-12
pubmed: 26667937
Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):512-521
pubmed: 28915128
Biomed Rep. 2013 Mar;1(2):213-217
pubmed: 24648921
Leuk Lymphoma. 2018 Aug;59(8):1959-1967
pubmed: 29164984
Asian Pac J Cancer Prev. 2011;12(5):1219-23
pubmed: 21875271
Anticancer Agents Med Chem. 2012 Oct 1;12(8):902-18
pubmed: 22292766
ScientificWorldJournal. 2013 Oct 27;2013:248532
pubmed: 24288468
Chin J Nat Med. 2015 Mar;13(3):163-82
pubmed: 25835361
Int J Mol Sci. 2018 Mar 09;19(3):null
pubmed: 29522491
Int J Antimicrob Agents. 2011 Feb;37(2):156-61
pubmed: 21163632
Oncotarget. 2016 Sep 20;7(38):61509-61519
pubmed: 27557491
Phytomedicine. 2014 Sep 25;21(11):1473-82
pubmed: 24916702
Oncotarget. 2018 Nov 20;9(91):36331-36343
pubmed: 30555632
Breast Cancer Res Treat. 2009 May;115(2):223-39
pubmed: 18636327
Evid Based Complement Alternat Med. 2017;2017:4269868
pubmed: 29279716
Cancer. 2014 Nov 15;120(22):3446-56
pubmed: 24948110
Curr Pharm Des. 2012;18(1):91-9
pubmed: 22211691
Cytokine Growth Factor Rev. 2010 Feb;21(1):11-9
pubmed: 20018552
Clin Exp Metastasis. 2018 Apr;35(4):309-318
pubmed: 29799080
Discov Med. 2009 Aug;8(41):61-3
pubmed: 19788869
Int J Clin Pharmacol. 1973 Apr;7(2):228-33
pubmed: 4269868
Lab Invest. 2001 Mar;81(3):349-60
pubmed: 11310828
J Ethnopharmacol. 2016 Jul 21;188:193-9
pubmed: 27178632
Eur J Med Chem. 2019 Jan 15;162:109-121
pubmed: 30439592
Am J Respir Cell Mol Biol. 2014 Jan;50(1):1-6
pubmed: 23980547
J Proteome Res. 2012 Feb 3;11(2):1302-16
pubmed: 22115128
Anticancer Drugs. 2015 Feb;26(2):210-23
pubmed: 25419632
Int J Oncol. 2016 Dec;49(6):2538-2548
pubmed: 27779641
Environ Toxicol. 2018 May;33(5):545-554
pubmed: 29385302